Search
Anrikefon
go.drugbank.com/drugs/DB21529InvestigationalAnrikefon is a small molecule drug. Anrikefon has a monoisotopic molecular weight of 703.44 Da.
Lefleuganan
go.drugbank.com/drugs/DB21533ExperimentalLefleuganan is a small molecule drug. Lefleuganan has a monoisotopic molecular weight of 1179.78 Da.
Orziloben
go.drugbank.com/drugs/DB21653ExperimentalOrziloben is a small molecule drug. Orziloben has a monoisotopic molecular weight of 222.13 Da.
Tegeprotafib
go.drugbank.com/drugs/DB21665ExperimentalTegeprotafib is a small molecule drug. Tegeprotafib has a monoisotopic molecular weight of 326.04 Da.
Vamagloxistat
go.drugbank.com/drugs/DB21666ExperimentalVamagloxistat is a small molecule drug. Vamagloxistat has a monoisotopic molecular weight of 371.11 Da.
Milpecitinib
go.drugbank.com/drugs/DB21676ExperimentalMilpecitinib is a small molecule drug. Milpecitinib has a monoisotopic molecular weight of 380.13 Da.
Claziprotamide
go.drugbank.com/drugs/DB21687ExperimentalClaziprotamide is a small molecule drug. Claziprotamide has a monoisotopic molecular weight of 374.13 Da.
Methyl-1-testosterone
go.drugbank.com/drugs/DB01572ExperimentalIllicitIt is a derivative of 1-testosterone with a methyl group in the carbon 17. Methyl-1-testosterone is considered a prohibited doping substance. … Methyl-1-testosterone is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use.
Synonyms: (5α,17β)-17-Hydroxy-17-methylandrost-1-en-3-one, 17alpha-Methyl-17beta-hydroxy-5alpha-androst-1-en-3-oneCyclopropane
go.drugbank.com/drugs/DB13984ExperimentalCyclopropane was initially investigated because it was thought to be the toxic element in ethylene. … Instead, it turned out to be an excellent anesthetic with very rapid onset and recovery while maintaining stable hemodynamics. Its use was ultimately limited because it was highly explosive.
Exicorilant
go.drugbank.com/drugs/DB16162InvestigationalExicorilant is under investigation in clinical trial NCT03437941 (Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With Mcrpc).